Tenascin-C inhibits β1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnlll 1-5 repeats to fibronectin

被引:0
作者
Hauzenberger, D [1 ]
Olivier, P [1 ]
Gundersen, D [1 ]
Rüegg, C [1 ]
机构
[1] Swiss Inst Expt Canc Res, CPO Lab, CH-1066 Epalinges, Switzerland
关键词
tenascin-C; cell adhesion; integrin;
D O I
10.1002/(SICI)1521-4141(199905)29:05<1435::AID-IMMU1435>3.0.CO;2-N
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The extracellular matrix consists of different proteins interacting to form a meshwork-like structure. T lymphocyte adhesion to individual matrix proteins is mainly regulated at the adhesion receptor level, but it is conceivable that the composition df the matrix itself may affect T lymphocyte adhesion to individual proteins. We have addressed the latter paint by studying the effect of the matrix protein tenascin-C (TN-C) on T lymphocyte adhesion to fibronectin. Here we report that TN-C inhibits adhesion of T lymphocytes and MOLT-4 lymphoma cells to fibronectin. We demonstrate that a TN-C fragment consisting of fibronectin type III repeats 1-5 (TNfnIII 1-5) but not TNfnIII A-D and TNfnIII 6-8 inhibited alpha 5 beta 1 and alpha 4 beta 1 integrin-mediated T lymphocyte and MOLT-4 adhesion to fibronectin. At concentrations that did not inhibit adhesion, TNfnIII 1-5 still prevented MOLT-4 cells from spreading on fibronectin. Preincubation and co-immobilization of TNfnIII 1-5 with fibronectin was more effective in inhibiting MOLT-4 adhesion to fibronectin than soluble TNfnIII 1-5 present during the adhesion test. Using an enzyme-linked immunosorbent assay we could demonstrate binding of TNfnIII 1-5 to fibronectin and fibronectin fragments. Taken together, these data demonstrate that the TNfnIII 1-5 domain is implicated in the inhibition of T lymphocyte adhesion to fibronectin caused by TN-C, and indicate that this effect involves the binding of TN-C repeats TNfnIII 1-5 to fibronectin.
引用
收藏
页码:1435 / 1447
页数:13
相关论文
共 45 条
[21]   Tenascin suppresses CD3-mediated T cell activation [J].
Hibino, S ;
Kato, K ;
Kudoh, S ;
Yagita, H ;
Okumura, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (01) :119-124
[22]  
HIGUCHI M, 1993, ACTA NEUROPATHOL, V85, P481
[23]  
LAZAROVITS AI, 1993, J IMMUNOL, V151, P6482
[24]   TENASCIN HEXABRACHION IN HUMAN-SKIN - BIOCHEMICAL-IDENTIFICATION AND LOCALIZATION BY LIGHT AND ELECTRON-MICROSCOPY [J].
LIGHTNER, VA ;
GUMKOWSKI, F ;
BIGNER, DD ;
ERICKSON, HP .
JOURNAL OF CELL BIOLOGY, 1989, 108 (06) :2483-2493
[25]   LOCALIZATION AND QUANTITATION OF HEXABRACHION (TENASCIN) IN SKIN, EMBRYONIC BRAIN, TUMORS, AND PLASMA [J].
LIGHTNER, VA ;
SLEMP, CA ;
ERICKSON, HP .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 580 :260-275
[26]  
LIGHTNER VA, 1990, J CELL SCI, V95, P263
[27]   INDUCTION OF TENASCIN IN HEALING WOUNDS [J].
MACKIE, EJ ;
HALFTER, W ;
LIVERANI, D .
JOURNAL OF CELL BIOLOGY, 1988, 107 (06) :2757-2767
[28]  
MACKIE EJ, 1994, PERSPECT DEV NEUROBI, V2, P125
[29]  
PESHEVA P, 1994, J CELL SCI, V107, P2323
[30]   CHARACTERIZATION OF MULTIPLE ADHESIVE AND COUNTERADHESIVE DOMAINS IN THE EXTRACELLULAR-MATRIX PROTEIN CYTOTACTIN [J].
PRIETO, AL ;
ANDERSSONFISONE, C ;
CROSSIN, KL .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :663-678